BRCA1 and breast carcinoma: A recent study used targeted sequencing of mitochondrial DNA in high-risk breast cancer patients negative for BRCA1/2 mutations to provide new clinical evidence for MT-CYB variants as a risk factor for hereditary breast cancers [33].